In a study involving more than 3,500 participants, no excess risk of dementia was established in relation to high cholesterol or statins.
The findings can be read in JAMA.
“This was a prospective cohort study performed from 2008 to 2018 in Norway. Statistical analysis was performed from January 2021 to February 2022,” according to the study’s authors.
“This study included individuals with genetically verified familial hypercholesterolemia (FH) and age-matched and sex-matched controls obtained from the general Norwegian population.”
What the study’s authors concluded: “These findings suggest that individuals with FH have no excess risk of dementia compared with age-matched and sex-matched controls and that there is no association between use of statins and risk of dementia in patients with FH.”
